Aegle Therapeutics is a first-in-class, phase 1/2a biotechnology company isolating extracellular vesicles including exosomes ("EVs") secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa ("DEB"), a rare genetic pediatric connective tissue disorder.

Biotechnology

Aegle Therapeutics

Aegle Therapeutics' headquarters in Woburn, MA, United States

Shelley A. Hartman

Heidi Kempinski

Evangelos V. Badiavas

Lonnie Moulder

Robert Williamson

David Schimel

Robert Ryan

Mike Tanji

This department encompasses senior management positions responsible for strategic decision-making and overall organizational direction.

Leadership Group

Aegle Therapeutics' Leadership Team includes Evangelos V. Badiavas and 4 others.

Aegle Therapeutics

Org chart

Board & advisors

Teams

Leadership Group

Leadership Team

Offices

Aegle Therapeutics

Org chart

Board & advisors

Teams

Leadership Group

Leadership Team

Offices

Related companies